Plants that express vaccine antigens are a viable strategy since recent advancements in immunology and molecular biology have resulted in the creation of novel vaccination tactics. There are a variety of systems to deliver vaccines but transgenic plants provide alternative means for the manufacture and distribution of vaccinations. It is less expensive, takes less time to transport, needs less refrigeration, and for a long time, it may be kept at room temperature to make in-plant edible vaccines. As a result, vaccines made from plants could be more broadly accessible in underdeveloped countries. Besides the advantages, there are a number of challenges in creating an edible vaccine, including dose, antigen choice, public image, the shelf life of the plants used as vaccines, and differentiation between "vaccine" fruit and regular fruit to prevent improper vaccination. Edible plant vaccines can increase both mucosal and systemic immunity. The best plants for making edible vaccines include tobacco, potato, tomato, and banana. Up to this point, plant-based vaccinations have been created to protect against illnesses including Cholera, Hepatitis, Malaria, Newcastle disease, Measles and the Rabies virus. Animal studies have shown that antigenic proteins produced from plants can delay the development of illness, and human therapeutic trials have demonstrated their safety and efficacy. There are currently very few approved vaccines made from edible plants that are being tested on both humans and animals. This paper examines recent developments, manufacturing techniques, and applications for edible vaccines.